LimmaTech Biologics
PrivateLast Round
Grant
Feb 17, 2025
Total Funding Raised
$51.87M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
LimmaTech Biologics is a biopharmaceutical company that specializes in the research, development, and production of innovative bioconjugate vaccines to prevent life-threatening diseases caused by antimicrobial-resistant pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LimmaTech Biologics Comparables
Compare LimmaTech Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omniose | 87% | |
| EveliQure Biotechnologies | 77% | |
| Inventprise | 76% | |
LimmaTech Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2025 | ||||
| Grant | Feb 27, 2024 | ||||
| Series A Extension | Feb 1, 2024 | ||||
| Series A | Oct 9, 2023 | ||||
| Seed | Oct 1, 2017 |
Key People
Founding team and executive leadership
LimmaTech Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| AXA IM Alts | Series A Extension, Series A |
| Novo Holdings | Series A |
| BNP Paribas Asset Management | Series A |
| AXA Investment Managers | Series A |
| Adjuvant Capital | Series A Extension, Series A |
| Tenmile | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 524% MoM, reaching 6.5K.
- Jun 23, 2026
Monthly visitors grew 74% MoM, reaching 1K.
LimmaTech Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LimmaTech Biologics's valuation, stock price, and market status.